Recent News
Invokana News: British Doctors’ Group Addresses SGLT2 Inhibitor – Ketoacidosis Risk
A British doctors’ group has released a new position statement calling on caregivers and patients to be aware of the potential for Invokana and other SGLT2 inhibitors to cause diabetic ketoacidosis, a potentially fatal condition. The new statement comes as … Continue reading
After St. Jude Merlin@home Hacking Controversy, FDA Issues Cybersecurity Guidance
Federal medical regulators have released final guidance to address the postmarket management of medical device cybersecurity. The issuance of the 30-page document comes just four months after hacking concerns involving St. Jude Medical’s Merlin@home monitoring system highlighted the potential threats … Continue reading
Bair Hugger Infection Lawsuits Focus of Upcoming Federal Conference
The federal litigation that now involves more than 900 Bair Hugger infection lawsuits is scheduled to convene its next Status Conference later this month. Such conferences generally provide the parties an opportunity to update the court on the progress of … Continue reading
Wrongful Death Lawsuit Filed Over Johnson & Johnson Baby Powder
A West Virginia woman has filed a Baby Powder lawsuit against Johnson & Johnson, following her mother’s death from ovarian cancer. The complaint accuses the healthcare products giant of deliberately ignoring research linking talc-based powders to the disease. According to … Continue reading
Nexium Lawsuit Seeks Compensation for Chronic Kidney Disease, Acute Kidney Injury
A Pennsylvania woman has filed a Nexium lawsuit on behalf of her late husband, who allegedly suffered chronic kidney disease, as well as acute kidney injury, due to treatment with the popular proton pump inhibitor. The complaint claims that Nexium’s … Continue reading
Invokana Lawsuits Move Forward, as Federal Litigation Schedules Initial Conference
The federal litigation established earlier this month for Invokana lawsuits is beginning to move forward. According to an Initial Order issued in the U.S. District Court, District of New Jersey, earlier this week, the proceeding will convene its first Case … Continue reading
Abilify Gambling Risk Confirmed by New Study
Findings from a new study appear to confirm the link between Abilify and compulsive gambling. The research, which will appear in the Journal of Clinical Psychopharmacology in February, suggests that patients who take Abilify are five times more likely to … Continue reading
Dexilant Lawsuit Added to Growing Proton Pump Inhibitor Litigation
A Kentucky woman has filed a Dexilant lawsuit after allegedly developing chronic kidney disease due to treatment with the proton pump inhibitor. Her complaint, which was filed on December 8th in the U.S. District Court, Northern District of Illinois, claims … Continue reading
Stryker Announces Expansion of Hip Recall Settlement
Stryker Corp. has expanded the $1 billion hip replacement settlement resulting from the recall of Rejuvenate and ABG II Modular-Neck hip stems. Patients who underwent hip revision surgery due to a recall-related reason prior to December 19, 2016 will now … Continue reading
Risperdal and Gynecomastia: “People Would Point and Stare”
Eddie Bible was just a teenager when he began taking Risperdal in the early 2000s. A year-and-half-later, Mr. Bible had developed gynecomastia, a condition that caused him to develop female-like breasts. “I had bigger boobs than the girls in (high) … Continue reading
Follow Us
